Biosciences in Action: Read the Fall 2026 Issue of BioMatters®
Michigan’s biosciences industry is powered by more than breakthrough discoveries. Behind every successful product are the technologies, specialized expertise, manufacturing capabilities, and partnerships needed to move innovation forward.
The Fall 2026 issue of BioMatters® brings those capabilities into focus with the theme “Biosciences in Action: Technologies, expertise, and partnerships powering Michigan’s bio-industry.” The issue highlights companies across Michigan that are solving complex challenges, expanding capabilities, and supporting the development and delivery of life-changing products.
Featured stories include:
- Keystone Solutions Group, demonstrating how listening to customer needs has driven the expansion of its medical device manufacturing capabilities and the launch of K2 Fabricating.
- Wacker Chemical Corporation, highlighting the advanced chemistry and materials expertise supporting healthcare, medical device, pharmaceutical, and other bioscience applications.
- M3D, bringing real-time gamma imaging into clinical workflows and advancing new applications in radiation safety and surgical oncology.
- Sterile State, developing a nitric oxide-based approach designed to transform medical device sterilization and reduce reliance on ethylene oxide.
- Pliant Medical, exploring how early collaboration and cleanroom precision can help shape a stronger approach to medical device manufacturing.
- NorthernBio, expanding its capabilities and capacity to support the evolving needs of the biosciences community.
- Oxford Biomedical Research, reflecting more than 40 years of scientific expertise and experience supporting researchers and customers.
Together, these stories offer a snapshot of biosciences in action — and the depth of expertise, infrastructure, and collaboration that makes Michigan’s bio-industry possible.
Read the full Fall 2026 issue of BioMatters® and discover the companies and capabilities helping move Michigan biosciences forward.
